Amicus Therapeutics Q4 2025 Earnings EPS Misses Expectations by a Wide Margin NGS Q1 2026 Earnings EPS Beats Estimates by 175 on Operational Strength EVTC Q1 2026 Earnings EPS Miss Sends Shares Lower Amid Revenue Uncertainty CIEN Q1 2026 Earnings Solid EPS Beat Despite Revenue Caution Stock Edges Up DCOMP Q1 2026 Earnings EPS Misses Estimates Stock Flat INAB Q1 2026 Earnings Narrowed Losses Exceed Expectations as Clinical Progress Continues MAGN Q1 2026 Earnings Significant EPS Miss Amidst Operational Challenges New England Realty Associates NEN Q4 2024 Earnings Partnership Reports Strong Earnings Per Unit Stock Unchanged RNTX Q1 2026 Earnings Narrowed Loss Beats Estimates as Rein Therapeutics Advances Pipeline iQSTEL Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines OS Q4 2025 Earnings Strong EPS Beat Driven by Operational Efficiency Upexi UPXI Q1 2026 Earnings Massive EPS Miss Highlights Operational Challenges